BA
The Boeing Company
BA's fundamentals are strong: its operating margin went from −10% to 10% and revenue grew 18%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
IVDA
Iveda Solutions, Inc.
There isn't enough reported data to score IVDA yet.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
IVDA Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Unavailable | |
| Unavailable |
IVDA's revenue and profitability are currently under pressure. There isn't enough data to rate its cash flow and balance sheet.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
IVDA PE Valuation
IVDA has no meaningful PE right now: it lost money over the past year.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
IVDA Forward outlook
There aren't enough analyst estimates for IVDA to show an outlook.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over IVDA on earnings quality, reporting a profit while its opponent remains loss making.
IVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.53 | +$0.88 |
| Q1 2026 | -$0.66 | +$0.79 |
| Q4 2025 | -$0.88 | +$0.85 |
| Q3 2025 | -$1.22 | +$0.32 |
| Q2 2025 | -$1.41 | +$0.27 |
| Q1 2025 | -$1.45 | +$0.39 |
| Q4 2024 | -$1.73 | -$0.13 |
| Q3 2024 | -$1.54 | +$0.06 |
IVDA is still losing money, but far less than before: $0.53 per share over the past year, against $8.32 at its worst in early 2016.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over IVDA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA has the edge over IVDA on profitability, with a higher operating margin.
IVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $801.8K | -48% |
| Q1 2026 | $1.5M | +1.3% |
| Q4 2025 | $626K | -64% |
| Q3 2025 | $1.7M | -31% |
| Q2 2025 | $1.5M | -0.4% |
| Q1 2025 | $1.5M | +325% |
| Q4 2024 | $1.7M | +70% |
| Q3 2024 | $2.4M | +175% |
IVDA's revenue has slid since its 2024 peak: $801,846 last quarter, down 48% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -89% | -54 points |
| Q1 2026 | -38% | +19 points |
| Q4 2025 | -263% | -160 points |
| Q3 2025 | -13% | +12 points |
| Q2 2025 | -35% | -1.3 points |
| Q1 2025 | -57% | +278 points |
| Q4 2024 | -103% | +7.4 points |
| Q3 2024 | -25% | +79 points |
IVDA's operating margin was −89% last quarter, down 54 points from the same quarter a year ago.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the stronger cash trend. Its trailing FCF is up 100% versus its history, compared with IVDA at up 14%.
IVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$927.1K | -$801.2K |
| Q3 2025 | -$317K | +$582.7K |
| Q2 2025 | -$1.3M | -$325.9K |
| Q1 2025 | -$126K | +$1.2M |
| Q4 2024 | -$1.2M | -$236.5K |
| Q3 2024 | -$899.7K | +$2M |
| Q2 2024 | -$1M | -342% |
| Q1 2024 | -$1.3M | -$1.3M |
IVDA has burned cash in almost every quarter: −$3M over the past year, against −$4M the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has the edge over IVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
IVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +32% | +2.9M shares |
| 1 year | +317% | +9M shares |
| 3 years | +519% | +9.9M shares |
| 5 years | +1212% | +10.9M shares |
| Available history | +2594% | +11.4M shares |
IVDA has 12M diluted shares, up 317% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
IVDA Net Leverage
IVDA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
IVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.2 | Neutral |
| Stochastic | 4.0 | Oversold |
IVDA's weekly RSI is 37 (neutral) and its Stochastic is 4 (oversold).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
IVDA PE vs Industrials Sector
IVDA has no meaningful PE right now: it lost money over the past year.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
IVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.24 | 17% below |
| 20 week MA | $0.28 | 29% below |
| 50 week MA | $0.42 | 52% below |
| 100 week MA | $1.35 | 85% below |
| 200 week MA | $3.78 | 95% below |
IVDA is in a downtrend: it's below all five of its weekly moving averages, and 95% below its 200-week average.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has the edge over IVDA on returns for 2026, with the stronger performance.
IVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.8 | $32.0 | +47% |
| 2021 | $32.0 | $128.6 | +302% |
| 2022 | $128.6 | $4.64 | -96% |
| 2023 | $4.64 | $5.07 | +9.3% |
| 2024 | $5.07 | $5.53 | +9.1% |
| 2025 | $5.53 | $0.89 | -84% |
| 2026 YTD | $0.89 | $0.20 | -78% |
IVDA's yearly returns have swung widely, from +302% in 2021 to −96% in 2022. It's down 78% so far in 2026.